A novel long non-coding RNA CYP4B1-PS1-001 regulates proliferation and fibrosis in diabetic nephropathy

Molecular and Cellular Endocrinology

Volumn 426, Issue , 2016, Pages 136-145

  Wang, Min ^a   Wang, Suyu ^a   Yao, Di ^a   Yan, Qin ^a   Lu, Weiping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Fibrosis; LncRNA; Proliferation

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; LONG NON-CODING RNA CYP4B1-PS1-001, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; FIBROSIS; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; COMPLICATION; GENETICS; HEK293 CELL LINE; HUMAN; KIDNEY; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE;

ANIMALS; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FIBROSIS; GENE EXPRESSION; HEK293 CELLS; HUMANS; KIDNEY; MALE; MICE, INBRED C57BL; RNA INTERFERENCE; RNA, LONG NONCODING;

EID: 84959536111     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.02.020     Document Type: Article

References (49)

1. Arora M.K., Singh U.K. Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update. Vasc. Pharmacol. 2013, 58(4):259-271. 10.1016/j.vph.2013.01.001.
2. Balakumar P., Kadian S., Mahadevan N. Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?. Pharmacol. Res. 2012, 65(4):430-436. 10.1016/j.phrs.2012.01.004.
3. Collins A.J., Foley R.N., Chavers B., Gilbertson D., Herzog C., Johansen K., Kasiske B., Kutner N., Liu J., St Peter W., Guo H., Gustafson S., Heubner B., Lamb K., Li S., Li S., Peng Y., Qiu Y., Roberts T., Skeans M., Snyder J., Solid C., Thompson B., Wang C., Weinhandl E., Zaun D., Arko C., Chen S.C., Daniels F., Ebben J., Frazier E., Hanzlik C., Johnson R., Sheets D., Wang X., Forrest B., Constantini E., Everson S., Eggers P., Agodoa L. 'United States renal data system 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am. J. kidney Dis. Official J. Natl. Kidney Found. 2012, 59(Suppl. 1):e1-e4420. A7. 10.1053/j.ajkd.2011.11.015.
4. Esteller M. Non-coding RNAs in human disease. Nature reviews. Genetics 2011, 12(12):861-874. 10.1038/nrg3074.
5. Folkersen L., Kyriakou T., Goel A., Peden J., Malarstig A., Paulsson-Berne G., Hamsten A., Hugh W., Franco-Cereceda A., Gabrielsen A., Eriksson P., Consortia P. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PloS One 2009, 4(11):e7677. 10.1371/journal.pone.0007677.
6. Fu X., Ravindranath L., Tran N., Petrovics G., Srivastava S. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol. 2006, 25(3):135-141. 10.1089/dna.2006.25.135.
7. Gervasini G., Luna E., Garcia-Cerrada M., Garcia-Pino G., Cubero J.J. Risk factors for post-transplant diabetes mellitus in renal transplant: role of genetic variability in the CYP450-mediated arachidonic acid metabolism. Mol. Cell. Endocrinol. 2016, 419:158-164. 10.1016/j.mce.2015.10.009.
8. Gray S.P., Cooper M.E. Diabetic nephropathy in 2010: alleviating the burden of diabetic nephropathy. Nature reviews. Nephrology 2011, 7(2):71-73. 10.1038/nrneph.2010.176.
9. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 2014, 103(2):137-149. 10.1016/j.diabres.2013.11.002.
10. Guo F., Li Y., Liu Y., Wang J., Li Y., Li G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochimica Biophysica Sinica 2010, 42(3):224-229.
11. Hajarnis S.S., Patel V., Aboudehen K., Attanasio M., Cobo-Stark P., Pontoglio M., Igarashi P. Transcription factor hepatocyte nuclear Factor-1beta (HNF-1beta) regulates MicroRNA-200 expression through a long noncoding RNA. J. Biol. Chem. 2015, 290(41):24793-24805. 10.1074/jbc.M115.670646.
12. He F., Peng F., Xia X., Zhao C., Luo Q., Guan W., Li Z., Yu X., Huang F. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia 2014, 57(8):1726-1736. 10.1007/s00125-014-3282-0.
13. Hu F.B. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011, 34(6):1249-1257. 10.2337/dc11-0442.
14. Ifere G.O., Ananaba G.A. Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression. Recent Pat. DNA Gene Sequences 2009, 3(3):151-163.
15. Johnson R. Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiol. Dis. 2012, 46(2):245-254. 10.1016/j.nbd.2011.12.006.
16. Jones C.A., Krolewski A.S., Rogus J., Xue J.L., Collins A., Warram J.H. epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?. Kidney Int. 2005, 67(5):1684-1691. 10.1111/j.1523-1755.2005.00265.x.
17. Kaikkonen M.U., Lam M.T., Glass C.K. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc. Res. 2011, 90(3):430-440. 10.1093/cvr/cvr097.
18. Karihaloo A. Anti-fibrosis therapy and diabetic nephropathy. Curr. Diabetes Rep. 2012, 12(4):414-422. 10.1007/s11892-012-0290-7.
19. Kato M., Putta S., Wang M., Yuan H., Lanting L., Nair I., Gunn A., Nakagawa Y., Shimano H., Todorov I., Rossi J.J., Natarajan R. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 2009, 11(7):881-889. 10.1038/ncb1897.
20. Koshimizu T.A., Fujiwara Y., Sakai N., Shibata K., Tsuchiya H. Oxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line. Life Sci. 2010, 86(11-12):455-460. 10.1016/j.lfs.2010.02.001.
21. Lameire N. Diabetes and diabetic nephropathy - a worldwide problem. Acta Diabetol. 2004, 41(Suppl. 1):S3-5. 10.1007/s00592-004-0130-6.
22. Li J., Ma W., Zeng P., Wang J., Geng B., Yang J., Cui Q. LncTar: a tool for predicting the RNA targets of long noncoding RNAs. Briefings Bioinforma. 2015, 16(5):806-812. 10.1093/bib/bbu048.
23. Matouk I.J., Abbasi I., Hochberg A., Galun E., Dweik H., Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur. J. Gastroenterol. Hepatol. 2009, 21(6):688-692.
24. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D.R., Hinds D.A., Pennacchio L.A., Tybjaerg-Hansen A., Folsom A.R., Boerwinkle E., Hobbs H.H., Cohen J.C. A common allele on chromosome 9 associated with coronary heart disease. Sci. (New York, N. Y. 2007, 316(5830):1488-1491. 10.1126/science.1142447.
25. Meier C., Kraenzlin M.E. Antiepileptics and bone health. Ther. Adv. Musculoskelet. Dis. 2011, 3(5):235-243. 10.1177/1759720X11410769.
26. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nature reviews. Genetics 2009, 10(3):155-159. 10.1038/nrg2521.
27. Panzitt K., Tschernatsch M.M., Guelly C., Moustafa T., Stradner M., Strohmaier H.M., Buck C.R., Denk H., Schroeder R., Trauner M., Zatloukal K. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132(1):330-342. 10.1053/j.gastro.2006.08.026.
28. Park E.C., Kim S.I., Hong Y., Hwang J.W., Cho G.S., Cha H.N., Han J.K., Yun C.H., Park S.Y., Jang I.S., Lee Z.W., Choi J.S., Kim S., Kim G.H. Inhibition of CYP4A reduces hepatic endoplasmic reticulum stress and features of diabetes in mice. Gastroenterology 2014, 147(4):860-869. 10.1053/j.gastro.2014.06.039.
29. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29(9):e45.
30. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136(4):629-641. 10.1016/j.cell.2009.02.006.
31. Qureshi I.A., Mattick J.S., Mehler M.F. Long non-coding RNAs in nervous system function and disease. Brain Res. 2010, 1338:20-35. 10.1016/j.brainres.2010.03.110.
32. Rangel L.B., Sherman-Baust C.A., Wernyj R.P., Schwartz D.R., Cho K.R., Morin P.J. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene 2003, 22(46):7225-7232. 10.1038/sj.onc.1207008.
33. Reutens A.T., Atkins R.C. Epidemiology of diabetic nephropathy. Contributions Nephrol. 2011, 170:1-7. 10.1159/000324934.
34. Spitale R.C., Tsai M.C., Chang H.Y. RNA templating the epigenome: long noncoding RNAs as molecular scaffolds. Epigenetics 2011, 6(5):539-543.
35. Spizzo R., Almeida M.I., Colombatti A., Calin G.A. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene 2012, 31(43):4577-4587. 10.1038/onc.2011.621.
36. Tam V.C. Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections. Seminars Immunol. 2013, 25(3):240-248. 10.1016/j.smim.2013.08.006.
37. TGF-beta induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy.pdf. doi:10.1126/scisignal.2003389.
38. The global challenge of diabetes The global challenge of diabetes. Lancet 2008, 371(9626):1723. 10.1016/S0140-6736(08)60733-3.
39. Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., Freier S.M., Bennett C.F., Sharma A., Bubulya P.A., Blencowe B.J., Prasanth S.G., Prasanth K.V. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 2010, 39(6):925-938. 10.1016/j.molcel.2010.08.011.
40. Tsai M.C., Spitale R.C., Chang H.Y. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011, 71(1):3-7. 10.1158/0008-5472.CAN-10-2483.
41. Van Buren P.N., Toto R. Current update in the management of diabetic nephropathy. Curr. Diabetes Rev. 2013, 9(1):62-77.
42. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 2011, 43(6):904-914. 10.1016/j.molcel.2011.08.018.
43. Yan B., Yao J., Liu J.Y., Li X.M., Wang X.Q., Li Y.J., Tao Z.F., Song Y.C., Chen Q., Jiang Q. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ. Res. 2015, 116(7):1143-1156. 10.1161/CIRCRESAHA.116.305510.
44. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., Shan Z., Liu J., Tian H., Ji Q., Zhu D., Ge J., Lin L., Chen L., Guo X., Zhao Z., Li Q., Zhou Z., Shan G., He J. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 2010, 362(12):1090-1101. 10.1056/NEJMoa0908292.
45. Yoon J.H., Abdelmohsen K., Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. J. Mol. Biol. 2013, 425(19):3723-3730. 10.1016/j.jmb.2012.11.024.
46. Yu W., Gius D., Onyango P., Muldoon-Jacobs K., Karp J., Feinberg A.P., Cui H. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 2008, 451(7175):202-206. 10.1038/nature06468.
47. Zhang Z., Peng H., Chen J., Chen X., Han F., Xu X., He X., Yan N. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett. 2009, 583(12):2009-2014. 10.1016/j.febslet.2009.05.021.
48. Zhou F., Xue M., Qin D., Zhu X., Wang C., Zhu J., Hao T., Cheng L., Chen X., Bai Z., Feng N., Gao S.J., Lu C. HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3beta signaling pathway. PloS One 2013, 8(1):e53145. 10.1371/journal.pone.0053145.
49. Zhu S., Zhang X.O., Yang L. Panning for long noncoding RNAs. Biomolecules 2013, 3(1):226-241. 10.3390/biom3010226.